💨 Abstract

Capricor Therapeutics Inc. reported a first-quarter loss of $24.4 million, or 53 cents per share, missing Wall Street's expectations of a 33 cents per share loss. The company's shares have dropped 48% year-to-date but rose 33% over the past year, closing at $7.22 on Tuesday. The report was generated using data from Zacks Investment Research.

Courtesy: wtop.com